
Anti-HIV Agents, Pyridones, United States Food and Drug Administration, HIV Infections, Amides, Heterocyclic Compounds, 4 or More Rings, Piperazines, United States, Drug Combinations, Drug Resistance, Viral, Emtricitabine, Humans, Drug Interactions, Tenofovir, Drug Approval, Heterocyclic Compounds, 3-Ring, Randomized Controlled Trials as Topic
Anti-HIV Agents, Pyridones, United States Food and Drug Administration, HIV Infections, Amides, Heterocyclic Compounds, 4 or More Rings, Piperazines, United States, Drug Combinations, Drug Resistance, Viral, Emtricitabine, Humans, Drug Interactions, Tenofovir, Drug Approval, Heterocyclic Compounds, 3-Ring, Randomized Controlled Trials as Topic
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
